- Home
- AEP vs TAK Comparison
AEP vs TAK Comparison
Compare AEP & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEP
- TAK
- Stock Information
- Founded
- AEP 1906
- TAK 1781
- Country
- AEP United States
- TAK Japan
- Employees
- AEP N/A
- TAK N/A
- Industry
- AEP Electric Utilities: Central
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- AEP Utilities
- TAK Health Care
- Exchange
- AEP Nasdaq
- TAK Nasdaq
- Market Cap
- AEP 51.3B
- TAK 43.9B
- IPO Year
- AEP N/A
- TAK N/A
- Fundamental
- Price
- AEP $96.31
- TAK $13.63
- Analyst Decision
- AEP Hold
- TAK
- Analyst Count
- AEP 16
- TAK 0
- Target Price
- AEP $97.07
- TAK N/A
- AVG Volume (30 Days)
- AEP 3.4M
- TAK 1.3M
- Earning Date
- AEP 11-06-2024
- TAK 10-31-2024
- Dividend Yield
- AEP 3.86%
- TAK 4.65%
- EPS Growth
- AEP 13.93
- TAK 49.73
- EPS
- AEP 4.97
- TAK 1.27
- Revenue
- AEP $19,602,200,000.00
- TAK $31,732,209,416.00
- Revenue This Year
- AEP $7.84
- TAK $4.41
- Revenue Next Year
- AEP $4.49
- TAK $1.09
- P/E Ratio
- AEP $19.37
- TAK $21.56
- Revenue Growth
- AEP 1.64
- TAK 9.43
- 52 Week Low
- AEP $75.22
- TAK $12.58
- 52 Week High
- AEP $105.18
- TAK $15.08
- Technical
- Relative Strength Index (RSI)
- AEP 46.39
- TAK 39.22
- Support Level
- AEP $92.51
- TAK $13.46
- Resistance Level
- AEP $97.15
- TAK $13.75
- Average True Range (ATR)
- AEP 1.97
- TAK 0.16
- MACD
- AEP -0.27
- TAK -0.01
- Stochastic Oscillator
- AEP 47.68
- TAK 21.15
About AEP American Electric Power Company Inc.
American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 42% of AEP's of capacity is coal, with the remainder from a mix of natural gas (27%), renewable energy and hydro (21%), nuclear (8%), and demand response (2%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.